Mucopolysaccharidosis Type I – Pipeline Insight, 2025:...

adicionou um novo artigo Sem categoria

2025-07-21 13:44:54

Mucopolysaccharidosis Type I – Pipeline Insight, 2025: Exploring Emerging Therapies and Future Treatment Potential

Mucopolysaccharidosis Type I is a rare genetic lysosomal storage disease caused by the lack of the alpha-L-iduronidase enzyme. This enzyme deficiency results in the buildup of glycosaminoglycans (GAGs) in tissues and organs, leading to a range of symptoms that vary in intensity—from mild to severe. The condition is categorized into three forms: Hurler syndrome, Hurler-Scheie syndrome, and...

0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior